Concentrations of SP-A and HSP70 are associated with polarization of macrophages in pleural effusions of non-small cell lung cancer

被引:19
作者
Kaczmarek, Mariusz [1 ]
Lagiedo, Malgorzata [1 ]
Masztalerz, Agnieszka [1 ]
Kozlowska, Magdalena [2 ]
Nowicka, Agata [3 ]
Brajer, Beata [3 ]
Batura-Gabryel, Halina [3 ]
Sikora, Jan [1 ]
机构
[1] Univ Med Sci, Dept Immunol, Chair Clin Immunol, Poznan, Poland
[2] Wiellcopolskie Ctr Pulmonol & Thoracosurg, Poznan, Poland
[3] Univ Med Sci, Dept Pulmonol Allergol & Pulm Oncol, Poznan, Poland
关键词
SP-A; Hsp70; Non-small cell lung cancer; Pleural effusions; Pleural macrophages; M1 vs M2; SURFACTANT PROTEIN-A; TUMOR-ASSOCIATED MACROPHAGES; HEAT-SHOCK; TRANSCRIPTION FACTORS; MOLECULAR-PATTERNS; INTERFERON-GAMMA; NECROSIS-FACTOR; EXPRESSION; CYTOKINES; ACTIVATION;
D O I
10.1016/j.imbio.2017.10.025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Damage-associated molecular pattern (DAMP) molecules can initiate an immune response through Toll-like receptors (TLRs). DAMPs are released from cells as a response to the extracellular danger and can be by-products of tissue damage. In cancer microenvironment necrotic cells release debris which has potency to become DAMPs. Non-small cell lung cancer (NSCLC) is often accompanied by pleural effusion (PE), which contains a variety of DAMPs. Surfactant protein A (SP-A) and heat shock protein 70 (Hsp70) are important DAMPs in the respiratory tract. The aim of this study was to determine a correlation between SP-A or Hsp70 and development of PE in the course of NSCLC. Moreover, we aimed to determine relationships between DAMPs and certain humoral factors associated with formation and persistence of PE as well as pleural-residing macrophages. In 34 PE samples, we estimated concentration of SP-A, Hsp70, IL-6, IL-18, G-CSF, M-CSF, SCF, SDF1 alpha, VEGF as well as the fraction of macrophages and their pattern of polarization. We have found correlations between the concentration of the SP-A and Hsp70 and the percentage of PE derived macrophages, also between concentrations of SP-A and Hsp70, and cytokines which participate in inflammation and processes involved in remodeling of extracellular matrix (ECM). Our data indicate an important role of SP-A during the development of PE associated with NSCLC. We suggest that measurement of concentration level of SP-A can be helpful in the course of diagnosis of malignant PE associated with NSCLC.
引用
收藏
页码:200 / 209
页数:10
相关论文
共 50 条
  • [41] Expression of cytokines in pleural effusions and corresponding cell lines of small cell lung cancer
    Rath, Barbara
    Stickler, Sandra
    Hochmair, Maximilian J.
    Hamilton, Gerhard
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (01) : 5 - 15
  • [42] PKCη Is a Novel Prognostic Marker in Non-small Cell Lung Cancer
    Krasnitsky, Ella
    Baumfeld, Yael
    Freedman, Janna
    Sion-Vardy, Netta
    Ariad, Samuel
    Novack, Victor
    Livneh, Etta
    ANTICANCER RESEARCH, 2012, 32 (04) : 1507 - 1513
  • [43] Mechanism of TCF21 Downregulation Leading to Immunosuppression of Tumor-Associated Macrophages in Non-Small Cell Lung Cancer
    Liu, Hong
    He, Run
    Yang, Xuliang
    Huang, Bo
    Liu, Hongxiang
    PHARMACEUTICS, 2023, 15 (09)
  • [44] Biomarkers of immunotherapy for non-small cell lung cancer
    Shirasawa, Masayuki
    Yoshida, Tatsuya
    Ohe, Yuichiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (01) : 13 - 22
  • [45] Emerging Targets in Non-Small Cell Lung Cancer
    Liu, Louisa
    Soler, Joshua
    Reckamp, Karen L.
    Sankar, Kamya
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
  • [46] Proteomics biomarkers for non-small cell lung cancer
    Kisluk, Joanna
    Ciborowski, Michal
    Niemira, Magdalena
    Kretowski, Adam
    Niklinski, Jacek
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2014, 101 : 40 - 49
  • [47] Targeting MEK in non-small cell lung cancer
    Lara, Matthew S.
    Blakely, Collin M.
    Riess, Jonathan W.
    CURRENT PROBLEMS IN CANCER, 2024, 49
  • [48] Pembrolizumab for the treatment of non-small cell lung cancer
    Lim, Sung Hee
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 397 - 406
  • [49] The Purinergic Landscape of Non-Small Cell Lung Cancer
    Janho Dit Hreich, Serena
    Benzaquen, Jonathan
    Hofman, Paul
    Vouret-Craviari, Valerie
    CANCERS, 2022, 14 (08)
  • [50] Clinicopathological features of intraoperative pleural lavage cytology for non-small cell lung cancer
    Ken Onodera
    Akira Sakurada
    Fumihiko Hoshi
    Jiro Abe
    Tohru Hasumi
    Satomi Takahashi
    Yasuki Saito
    Yoshinori Okada
    General Thoracic and Cardiovascular Surgery, 2020, 68 : 164 - 169